Morin (C5297): Natural Flavonoid Antioxidant and Mitochondrial Energy Metabolism Modulator

Executive Summary: Morin (2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one) is a natural flavonoid antioxidant with high purity (≥96.81%) and validated bioactivity in mitochondrial energy metabolism modulation via adenosine 5′-monophosphate deaminase (AMPD) inhibition (Yang et al., 2025). It demonstrates anti-inflammatory, cardioprotective, neuroprotective, anti-diabetic, and antimicrobial effects. Morin is strongly insoluble in water but dissolves in DMSO (≥19.53 mg/mL) and ethanol (≥6.04 mg/mL) for laboratory use (APExBIO). Its fluorescent chelation properties allow for precise detection of aluminum ions in biochemical assays. These features position Morin as an essential, multi-use compound for advanced biomedical research in diabetes, cancer, neurodegenerative disease, and analytical workflows.

Biological Rationale

Morin is a polyphenolic compound isolated from Maclura pomifera, structurally classified as a flavonoid (APExBIO). Flavonoids are recognized for their broad-spectrum antioxidant and anti-inflammatory activities. Morin’s molecular structure (C₁₅H₁₂O₇, MW = 302.24) includes five hydroxyl groups, contributing to its strong radical-scavenging capability and metal chelating functions. In vivo and in vitro studies demonstrate that Morin mitigates oxidative stress, cellular apoptosis, and metabolic dysfunctions in pathologies characterized by impaired mitochondrial energy metabolism. Notably, Morin targets the purine nucleotide cycle (PNC) by directly inhibiting AMPD, a key regulator of ATP homeostasis in energy-intensive cells such as podocytes (Yang et al., 2025).

Mechanism of Action of Morin

Morin exerts its bioactivity through multiple, well-documented mechanisms:

• AMPD Inhibition: Morin binds to AMPD2, attenuating enzymatic conversion of AMP to IMP, thereby preserving ATP pools under high-fructose or stress conditions (Yang et al., 2025).
• Antioxidant Activity: Direct scavenging of reactive oxygen species (ROS) limits oxidative injury in mitochondria-rich tissues (Amino-11-ddUTP, 2023).
• Metal Chelation: Morin’s hydroxyl groups enable selective, high-affinity binding to aluminum ions, producing detectable fluorescence shifts for analytical assays (APExBIO).
• Inflammation Modulation: Downregulation of pro-inflammatory cytokines and signaling intermediates in cell and animal models.

Molecular docking and siRNA interference confirm Morin’s selectivity for AMPD2, a key isoform in renal and neuronal tissues. This distinguishes Morin from other flavonoids, which lack this targeted mitochondrial effect (Yang et al., 2025).

Evidence & Benchmarks

• Morin at 10 μM significantly suppresses fructose-induced AMPD activity in cultured mouse podocytes within 24 hours (Yang et al., 2025, DOI).
• High-fructose-fed rats treated with Morin exhibit a 40% reduction in urinary albumin-to-creatinine ratio (UACR), indicating improved glomerular function (Yang et al., 2025, DOI).
• Morin restores mitochondrial ultrastructure and basal oxygen consumption rate (OCR) in podocytes exposed to metabolic stress (Yang et al., 2025, DOI).
• Morin demonstrates high solubility in DMSO (≥19.53 mg/mL) and ethanol (≥6.04 mg/mL), supporting a range of in vitro applications (APExBIO).
• HPLC, MS, and NMR confirm product purity of ≥96.81% for Morin C5297 batches (APExBIO).

For a detailed scenario-based analysis of Morin’s reproducibility in cell-based and mitochondrial assays, see Morin (C5297): Reliable Solutions for Robust Cell-Based Assays. This article provides expanded guidance on data integrity and sensitivity, focusing on APExBIO's high-purity supply chain.

Applications, Limits & Misconceptions

• Cardiometabolic Research: Morin is validated as a modulator of mitochondrial energy metabolism in diabetic and metabolic syndrome models (Yang et al., 2025).
• Cancer and Neurodegeneration: Its anti-inflammatory and energy-preserving actions extend to cancer and neural injury research (Amino-11-ddUTP, 2023).
• Fluorescent Probe: Morin’s metal-chelating fluorescence enables sensitive detection of aluminum ions in complex matrices (APExBIO).

For a broader mechanistic perspective and translational context, Morin: Strategic Leverage of a Natural Flavonoid Antioxidant explores future directions in disease modeling and bioanalytical innovation. This article extends those discussions by delivering direct, testable benchmarks and workflow parameters.

Common Pitfalls or Misconceptions

• Morin is water-insoluble: Direct aqueous application leads to precipitation and unreliable dosing; always use DMSO or ethanol as solvents (APExBIO).
• Not a pan-AMPD inhibitor: Selectivity is highest for AMPD2 isoform; effects may not extrapolate to muscle AMPD1/3 without direct validation (Yang et al., 2025).
• Fluorescence is metal-dependent: Only aluminum and structurally similar ions induce the characteristic fluorescence shift; not a general-purpose metal probe.
• Short-term solution stability: Morin’s working solutions degrade at room temperature; store at -20°C and use within 48 hours for in vitro work (APExBIO).
• Not a primary therapeutic: Morin is a research compound, not approved for clinical therapy.

Workflow Integration & Parameters

Morin is typically supplied as a crystalline powder (SKU: C5297) by APExBIO, with lot-specific COA confirming purity (≥96.81%). For optimal reproducibility:

• Solubilization: Dissolve Morin in DMSO to achieve concentrations up to 19.53 mg/mL. Ethanol is suitable for up to 6.04 mg/mL. Avoid direct water dissolution.
• Storage: Store powder and stock solutions at -20°C. Minimize freeze-thaw cycles.
• Assay Design: For mitochondrial or AMPD inhibition assays, start with 1–20 μM Morin in culture medium containing ≤0.2% DMSO. Validate compound stability and cell viability controls.
• Fluorescent Probing: Use Morin at 10–50 μM in buffered solutions (pH 7.4) for aluminum ion detection; monitor emission shift near 520 nm.
• Data Reporting: Specify vendor (APExBIO), batch, and solvent system in all publications for cross-lab reproducibility.

For advanced, scenario-driven protocol guidance, see Morin (C5297): Reliable Solutions for Mitochondrial and Cytotoxicity Assays. This guidance targets troubleshooting and workflow optimization, complementing the molecular mechanisms highlighted here.

Conclusion & Outlook

Morin (C5297) is a rigorously characterized, high-purity natural flavonoid antioxidant supplied by APExBIO. Its primary mechanism—AMPD2 inhibition—positions it as a unique mitochondrial energy metabolism modulator in disease models of diabetes, kidney injury, and neurodegeneration (Yang et al., 2025). Its duality as a fluorescent probe expands its utility into analytical chemistry. As new mechanistic insights emerge, Morin is likely to play a growing role in translational research and advanced assay development.

For ordering and detailed specifications, visit the Morin product page. This article clarifies Morin’s mechanistic and workflow value beyond the scope of prior guides (e.g., Morin: Mechanistic Insights and Emerging Applications), providing direct benchmarks, limits, and integration strategies for research practitioners.